Argitalpenak (27) RAFAEL CARRETERO COCA argitalpenak

filter_list

2024

  1. Discovery of BAY-405: An Azaindole-Based MAP4K1 Inhibitor for the Enhancement of T-Cell Immunity against Cancer

    Journal of Medicinal Chemistry, Vol. 67, Núm. 19, pp. 17429-17453

  2. Pericyte phenotype switching alleviates immunosuppression and sensitizes vascularized tumors to immunotherapy in preclinical models

    Journal of Clinical Investigation, Vol. 134, Núm. 18

  3. The Alliance Between the German Cancer Research Center and Bayer: A Retrospective of an Innovative Collaboration Model

    Handbook of Experimental Pharmacology (Springer Science and Business Media Deutschland GmbH), pp. 83-95

2023

  1. Secretogranin II influences the assembly and function of MHC class I in melanoma

    Experimental Hematology and Oncology

  2. Targeting the aryl hydrocarbon receptor (AhR) with BAY 2416964: A selective small molecule inhibitor for cancer immunotherapy

    Journal for ImmunoTherapy of Cancer, Vol. 11, Núm. 11

2022

  1. Rgs16 promotes antitumor CD8+ T cell exhaustion

    Science Immunology, Vol. 7, Núm. 71

  2. T cell-mediated elimination of cancer cells by blocking CEACAM6–CEACAM1 interaction

    OncoImmunology, Vol. 11, Núm. 1

2017

  1. Basophils promote tumor rejection via chemotaxis and infiltration of CD8+ T cells

    Cancer Research, Vol. 77, Núm. 2, pp. 291-302

2016

  1. Erratum : Corrigendum: Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8 + T cells (Nature Immunology)

    Nature Immunology

  2. Macrophage-derived nitric oxide initiates T-cell diapedesis and tumor rejection

    OncoImmunology, Vol. 5, Núm. 10

2015

  1. Antibody therapy to human L1CAM in a transgenic mouse model blocks local tumor growth but induces EMT

    International Journal of Cancer, Vol. 136, Núm. 5, pp. E326-E339

  2. Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8 + T cells

    Nature Immunology, Vol. 16, Núm. 6, pp. 609-617

  3. Radiotherapy combined with TLR7/8 activation induces strong immune responses against gastrointestinal tumors

    Oncotarget, Vol. 6, Núm. 7, pp. 4663-4676

2014

  1. Involvement of HLA class i molecules in the immune escape of urologic tumors

    Actas Urologicas Espanolas

2013

  1. A transcriptome-proteome integrated network identifies endoplasmic reticulum thiol oxidoreductase (ERp57) as a hub that mediates bone metastasis

    Molecular and Cellular Proteomics, Vol. 12, Núm. 8, pp. 2111-2125

  2. VEGF polymorphisms are not associated with an increased risk of developing renal cell carcinoma in Spanish population

    Human Immunology, Vol. 74, Núm. 1, pp. 98-103

2012

  1. Association between C13ORF31, NOD2, RIPK2 and TLR10 polymorphisms and urothelial bladder cancer

    Human Immunology, Vol. 73, Núm. 6, pp. 668-672

  2. Correlates between host and viral transcriptional program associated with different oncolytic vaccinia virus isolates

    Human Gene Therapy Methods, Vol. 23, Núm. 5, pp. 285-296

  3. Regression of melanoma metastases after immunotherapy is associated with activation of antigen presentation and interferon-mediated rejection genes

    International Journal of Cancer, Vol. 131, Núm. 2, pp. 387-395

2011

  1. Bacillus Calmette-Guerin immunotherapy of bladder cancer induces selection of human leukocyte antigen class I-deficient tumor cells

    International Journal of Cancer, Vol. 129, Núm. 4, pp. 839-846